Riskpilot← Back to searchSign inGet full accessColumna Utveckling AB
ABActiveOrg 5567959563Kanalgatan 51General medical practice activities · NACE 8621Est. 20091 employees
Revenue 2024
SEK 756K
+2% vs 2023
EBITDA margin
51.7%
-5% vs 2023
Equity ratio
72.0%
Financial strength
Net profit 2024
SEK 330K
+5% vs 2023
| Revenue | SEK 756K | +2% |
| EBITDA | SEK 391K | -5% |
| Net profit | SEK 330K | +5% |
| Total assets | SEK 789K | -1% |
| Equity | SEK 568K | -3% |
| Employees | 1 | — |
Legal name
Columna Utveckling AB
Org number
5567959563
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
3 december 2009
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva läkarpraktik och handel med värdepapper samt därmed förenlig verksamhet.
Address
Kanalgatan 51
Phone
+46706710282
Email
lazze51@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 759 | 932 | 847 | 744 | 756 |
| Staff expenses | — | — | −257 | −301 | — |
| EBITDA | 492 | 675 | 555 | 411 | 391 |
| Depreciation & amort. | −0 | −0 | — | — | −0 |
| EBIT | 492 | 675 | 555 | 411 | 391 |
| Net financials | −1 | — | −2 | −11 | 22 |
| Profit before tax | 541 | 675 | 554 | 400 | 413 |
| Tax | −116 | −139 | −116 | −86 | −83 |
| Net profit | 425 | 536 | 438 | 313 | 330 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 799 | 949 | 865 | 801 | 789 |
| Equity | 525 | 636 | 624 | 588 | 568 |
| Long-term debt | 0 | 0 | — | — | 0 |
| Short-term debt | 274 | 313 | 240 | 213 | 222 |
| Total debt | 274 | 313 | 240 | 213 | 222 |
EBITDA margin
51.7%
This company
15.8%
Market median
+227% vs market
20202024
Equity ratio
72.0%
This company
38.2%
Market median
+88% vs market
20202024
Return on equity
58.1%
This company
18.4%
Market median
+216% vs market
20202024
Net profit margin
43.7%
This company
8.1%
Market median
+440% vs market
20202024
Asset turnover
0.96×
This company
1.12×
Market median
+14% vs market
20202024
Debt / equity
0.39×
This company
0.62×
Market median
+37% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
MU Deputy Chief Executive Officer | Deputy Chief Executive Officer | 2022 |
LA Chief Executive Officer | Chief Executive Officer | 2022 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Columna Utveckling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Maud Ulla Gunilla Bohman | Deputy Chief Executive Officer | 0 companies |
| Lars-Erik Axel Henningsson | Chief Executive Officer | 0 companies |